Trial Profile

Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP)

Status: Discontinued

Phase of Trial: Phase I/II

Latest Information Update: 22 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mirtazapine (Primary)
Indications Hyperemesis gravidarum; Nausea and vomiting
Focus Therapeutic Use
Acronyms E-SNAP

Most Recent Events

15 Nov 2024 According to ClinicalTrials.gov: US National Institutes of Health, this trial has been withdrawn due to transfer of PI to new organization
22 Apr 2024 Status changed from recruiting to discontinued.
20 Sep 2023 Planned End Date changed from 13 Jun 2024 to 13 Jun 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com